PL117323B1 - Process for preparing novel n-aryl-n-/4-piperidinyl/-arylacetamidesetoamidov - Google Patents

Process for preparing novel n-aryl-n-/4-piperidinyl/-arylacetamidesetoamidov Download PDF

Info

Publication number
PL117323B1
PL117323B1 PL1976216213A PL21621376A PL117323B1 PL 117323 B1 PL117323 B1 PL 117323B1 PL 1976216213 A PL1976216213 A PL 1976216213A PL 21621376 A PL21621376 A PL 21621376A PL 117323 B1 PL117323 B1 PL 117323B1
Authority
PL
Poland
Prior art keywords
formula
parts
piperidinyl
cyclo
iso
Prior art date
Application number
PL1976216213A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL117323B1 publication Critical patent/PL117323B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL1976216213A 1975-09-23 1976-09-22 Process for preparing novel n-aryl-n-/4-piperidinyl/-arylacetamidesetoamidov PL117323B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
PL117323B1 true PL117323B1 (en) 1981-07-31

Family

ID=27087421

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1976216213A PL117323B1 (en) 1975-09-23 1976-09-22 Process for preparing novel n-aryl-n-/4-piperidinyl/-arylacetamidesetoamidov
PL19257876A PL192578A1 (pl) 1975-09-23 1976-09-22 Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL19257876A PL192578A1 (pl) 1975-09-23 1976-09-22 Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow

Country Status (29)

Country Link
JP (1) JPS6016417B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT363935B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU510029B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG27543A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1068271A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH628623A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS222663B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2642856A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK150478C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES451768A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI61482C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2325377A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1539473A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR58469B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU172964B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE43802B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL50522A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1073893B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU75837A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL187267C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO147672C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ181972A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH12497A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL117323B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT65631B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (1) RO70079A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE427839B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU747424A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU39973B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
US8906921B2 (en) 2007-04-23 2014-12-09 Janssen Pharmaceutica Nv 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
US8933101B2 (en) 2007-04-23 2015-01-13 Janssen Pharmaceutica Nv Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
US20100137368A1 (en) * 2007-04-23 2010-06-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
US8530474B2 (en) 2008-07-03 2013-09-10 Janssen Pharmaceutica Nv Substituted 6-(1-piperazinyl)-pyridazines as 5-HT6 receptor antagonists
DK2307374T3 (en) 2008-07-31 2017-05-01 Janssen Pharmaceutica Nv PIPERAZIN-1-YLTRIFLUORMETHYL-SUBSTITUTED PYRIDINES AS QUICK DISSOCATING DOPAMIN-2 RECEPTOR ANTAGONISTS
CN118496638B (zh) * 2024-07-22 2024-11-22 海安浩驰科技有限公司 一种抗紫外车窗膜及其制备方法

Also Published As

Publication number Publication date
SE7610501L (sv) 1977-03-24
PH12497A (en) 1979-04-05
LU75837A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-05-04
IE43802L (en) 1977-03-23
SU747424A3 (ru) 1980-07-23
JPS5239683A (en) 1977-03-28
ES451768A1 (es) 1978-05-01
YU39973B (en) 1985-06-30
DE2642856A1 (de) 1977-03-24
BG27543A3 (bg) 1979-11-12
AT363935B (de) 1981-09-10
DK150478C (da) 1987-10-05
PT65631A (en) 1976-10-01
NL7610513A (nl) 1977-03-25
DK427876A (da) 1977-03-24
DE2642856C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-06-21
IL50522A (en) 1979-09-30
YU233676A (en) 1983-01-21
CA1068271A (en) 1979-12-18
IL50522A0 (en) 1976-11-30
FR2325377B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-04-18
IE43802B1 (en) 1981-06-03
ATA702976A (de) 1981-02-15
AU510029B2 (en) 1980-06-05
SE427839B (sv) 1983-05-09
NZ181972A (en) 1978-07-28
AU1787876A (en) 1978-03-23
NL187267C (nl) 1991-08-01
GB1539473A (en) 1979-01-31
CH628623A5 (en) 1982-03-15
FI762698A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-03-24
JPS6016417B2 (ja) 1985-04-25
CS222663B2 (en) 1983-07-29
GR58469B (en) 1977-10-14
NO147672B (no) 1983-02-14
NO763054L (no) 1977-03-24
FI61482B (fi) 1982-04-30
NO147672C (no) 1983-05-25
DK150478B (da) 1987-03-09
RO70079A (ro) 1982-10-26
HU172964B (hu) 1979-01-28
FI61482C (fi) 1982-08-10
PL192578A1 (pl) 1979-02-26
IT1073893B (it) 1985-04-17
FR2325377A1 (fr) 1977-04-22
PT65631B (en) 1978-07-05
NL187267B (nl) 1991-03-01

Similar Documents

Publication Publication Date Title
FI81567C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-substituerade 4-oxipiperidinfoereningar.
DE69007429T2 (de) Isoindolonderivate, ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DE68920482T2 (de) 1-Indolylalkyl-4-(substituierte Pyridinyl)-Piperazine.
JP4324652B2 (ja) 鎮痛効果を有する新規な化合物
CN100439330C (zh) 芳族羟苯基和芳族硫基苯基衍生物
PL117323B1 (en) Process for preparing novel n-aryl-n-/4-piperidinyl/-arylacetamidesetoamidov
CZ20031386A3 (cs) Amidoalkylpiperidinové a amidoalkylpiperazinové deriváty vhodné k léčení chorob nervového systému
EP0304888B1 (en) Sulfonamidolphenyl derivates and therapeutic and preventive agents for arrythmia containing same
PL127483B1 (en) Method of obtaining new derivatives of 1-/cyclohexylo/-4-acrylo-4-piperidinylocarboxylic acid
CS258149B2 (en) Method of arylcyclobutylalkylamines production
PT91574B (pt) Processo para a preparacao de n-cicloalquil-benzilaminas a,a-di-substituidas uteis como medicamentos
DE69010285T2 (de) Als Spasmolytica geeignete Dibenzothiazepin-Derivate.
IE44362B1 (en) Dibenzocycloheptenylidene piperidines
US5916889A (en) 1,4-disubstituted piperazines
US6518284B2 (en) 4-substituted piperidines
DE69007126T2 (de) Muscarin-rezeptor-antagonisten.
SK277973B6 (en) 1,2 - etanediole derivatives and their salts, and method of their production
AU2007258871B2 (en) Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
EP1002794B1 (en) 4-¬(Aryl)(aryloxy)methyl piperidine derivatives and their use as serotonin and/or noradrenaline reuptake inhibitors
JP2006508946A (ja) 4(フェニル−ピペラジニル−メチル)ベンズアミド誘導体、および疼痛または胃腸障害の治療のためのその使用
Rémond et al. Pharmacological profile of a novel series of NK1 antagonists. In vitro and in vivo potency of benzimidazolone derivatives
JP2006514617A (ja) 疼痛または胃腸障害の治療のためのフェニル−ピペリジン−4−イリデン−メチル−ベンズアミド誘導体
WO2004101518A1 (en) 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
EP0158283A2 (en) Substituted 1-aminoalkylamino-4-aryloxypiperidines, a process for their preparation, intermediates thereof, and their use as medicaments
CS225004B1 (en) The production of the derivate of 3-amine-delta raised to the square-pyrasoline